Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,605 total articles

Powerful NeOnc Brain Cancer Pipeline Advances

Powerful NeOnc Brain Cancer Pipeline Advances

NeOnc Technologies Holdings (NASDAQ: NTHI) is set to meet with the FDA on November 17, 2026, to discuss its experimental brain cancer drug NEO212. This End-of-Phase 1 meeting could pave the way for Phase 2 development and a potential accelerated approval pathway. Early Phase 1 data shows promising tumor reduction and disease control in some patient…

Treasure Global Signs MOU for US$38 Million Acquisition of 51% Controlling Stake in Smart Water Metering Company

Treasure Global Signs MOU for US$38 Million Acquisition of 51% Controlling Stake in Smart Water Metering Company

Treasure Global Inc., a Nasdaq-listed Southeast Asian technology company, announced a $38 million acquisition of a 51% controlling stake in Malaysian smart water metering provider Mestiz Century Logic. The acquisition will expand Treasure Global's technology portfolio into smart utility infrastructure, leveraging AI, IoT, and cloud-based solutions …

Kinetic Reaches 38,000 Fiber Homes in Concord

Kinetic Reaches 38,000 Fiber Homes in Concord

Kinetic, a fiber internet provider and business unit of Uniti (NASDAQ: UNIT), announced a 23% expansion of its fiber network in Concord, North Carolina, now reaching over 38,000 homes. This milestone highlights Kinetic's investment and commitment to supporting local economic growth, education, telehealth, and small businesses. To celebrate, the com…

Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study

Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study

Oncolytics Biotech has activated nearly all clinical sites for its REO 033 randomized trial investigating pelareorep in combination with FOLFIRI and bevacizumab for RAS-mutant, microsatellite-stable metastatic colorectal cancer. The company anticipates sufficient data from Part A to provide an interim update by year-end 2026. FDA alignment suggests…

LOBO Enters AI‑Powered Community‑and Home-Based Senior Care Market, Targeting China’s Silver Economy

LOBO Enters AI‑Powered Community‑and Home-Based Senior Care Market, Targeting China’s Silver Economy

LOBO TECHNOLOGIES LTD., a US-listed manufacturer of electric mobility products and AI service provider, announced its strategic entry into the AI-powered community and home-based senior care market in China. The company is developing an integrated platform combining intelligent mobility devices, health wearables, AI analytics, and community care se…

Columbus Acquisition Corp Announces Adjournment of Reconvened Extraordinary General Meeting of the Shareholders

Columbus Acquisition Corp Announces Adjournment of Reconvened Extraordinary General Meeting of the Shareholders

Columbus Acquisition Corp, a special purpose acquisition company (SPAC), announced the adjournment of its reconvened Extraordinary General Meeting without conducting any business, rescheduling it to September 29, 2026. The meeting concerns shareholder approval of a proposed business combination with WISeSat.Space Corp. Shareholders can still vote, …

22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative

22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative

22nd Century Group highlights a French health agency's recommendation for maximum nicotine limits in combustible tobacco products, recognizing 22nd Century's proprietary reduced-nicotine tobacco as the only commercially available solution. The company now offers non-GMO reduced-nicotine tobacco to support French and EU regulatory efforts, potential…

EnerSyn Global Inc. Announces Second Nigeria Energy Investment: Lagos CNG Mother Station Project

EnerSyn Global Inc. Announces Second Nigeria Energy Investment: Lagos CNG Mother Station Project

EnerSyn Global Inc. announced the planned acquisition of a majority stake in Hearty Nova Limited, enabling participation in China Gas Africa Clean Energy Investment Holdings Limited’s new Lagos CNG Mother Station project. This energy project aims to supply compressed natural gas to West Africa’s largest economic hub with an expected internal rate o…

Quantum X Labs Enhances Its Quantum Platform for Defense and Aerospace with Unique Combination of Atomic Clock and Rydberg RF Sensing Technologies

Quantum X Labs Enhances Its Quantum Platform for Defense and Aerospace with Unique Combination of Atomic Clock and Rydberg RF Sensing Technologies

Quantum X Labs Inc. announced progress on combining their patent-pending quantum atomic clock technology with Rydberg atom-based RF sensing, aiming to create a unified atom-based sensing platform. This integrated solution targets enhanced precision timing and RF environmental sensing for defense and aerospace industries amid evolving electromagneti…

Hyperion DeFi Supports D3’s Frontier Vault Launch, Bringing Internet Domain Priority Access to the Hyperliquid Ecosystem

Hyperion DeFi Supports D3’s Frontier Vault Launch, Bringing Internet Domain Priority Access to the Hyperliquid Ecosystem

Hyperion DeFi announces its role as a launch partner for Frontier's Hyperliquid Vault, a new membership program that provides priority access to the upcoming expansion of internet top-level domains (TLDs). This initiative leverages D3's Doma Protocol to tokenize domain assets onchain, integrating real-world domain markets into the Hyperliquid block…

Exyn Technologies CEO Letter Highlights Growing Pipeline and Accelerating Momentum in Defense and Physical AI

Exyn Technologies CEO Letter Highlights Growing Pipeline and Accelerating Momentum in Defense and Physical AI

Exyn Technologies, a leader in physical AI for autonomous mapping in GPS-denied environments, reports strong momentum driven by growing defense and government engagements, including contracts with the U.S. Air Force and Army Corps of Engineers. The company’s autonomous solutions have delivered significant operational efficiencies in commercial mini…

All In FutureTech Alliance Inc. Launches New Corporate Website, Highlighting Its AI-Driven Business Strategy and Global Platform Vision

All In FutureTech Alliance Inc. Launches New Corporate Website, Highlighting Its AI-Driven Business Strategy and Global Platform Vision

All In FutureTech Alliance Inc. (NASDAQ: AIFA) has launched a new corporate website to better communicate its AI-focused business strategy and global platform vision. Under new leadership, the company emphasizes building an AI-enabled platform serving global Chinese-speaking communities through education, media content, cross-border commerce, and i…

Riverview Bancorp Declares 47th Consecutive Quarterly Cash Dividend

Riverview Bancorp Declares 47th Consecutive Quarterly Cash Dividend

Riverview Bancorp, Inc. announced that its Board of Directors approved a quarterly cash dividend of $0.02 per share, unchanged from the previous quarter. This marks the company's 47th consecutive quarterly dividend. The dividend will be paid on October 20, 2026, to shareholders of record as of October 9, 2026. Riverview Bancorp operates as a commun…

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

Palisade Bio announced that its lead drug candidate, PALI-2108, designed for inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease, will be featured in four presentations at UEG Week 2026. The data showcase early clinical efficacy, gut-targeted exposure, favorable safety profile, and a biomarker development to predict treatment…

Telos Corporation Awarded $13.7 Million Contract to Modernize Cyber Risk Management for U.S. Department of Health and Human Services

Telos Corporation Awarded $13.7 Million Contract to Modernize Cyber Risk Management for U.S. Department of Health and Human Services

Telos Corporation has been awarded an $13.7 million contract by the U.S. Department of Health and Human Services to deploy its FedRAMP-authorized Xacta cybersecurity platform and related services over 18 months. The contract aims to modernize cyber governance, risk, and compliance processes for HHS, integrating AI-powered tools to streamline securi…

Lifecore Biomedical to be Acquired by Webster Equity Partners

Lifecore Biomedical to be Acquired by Webster Equity Partners

Lifecore Biomedical has agreed to be acquired by Webster Equity Partners in a transaction valued up to $663.7 million including contingent value rights based on future performance milestones. Common stockholders will receive $6.28 per share in cash at closing, representing a 49.5% premium, plus CVRs up to $160 million contingent on milestones throu…

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit

GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit

GRI Bio, Inc., a clinical-stage biotech company developing therapies for fibrotic and autoimmune diseases, announced that its CEO and CSO will present at the upcoming 10th IPF Summit. They will share insights from Phase 2a clinical development of GRI-0621, an oral RAR β/γ-selective agonist targeting idiopathic pulmonary fibrosis (IPF). The presenta…